Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063078) titled 'Effects of Balenine-Containing Whale Meat Extract Supplementation on Skin Conditioning in Healthy Female University Students' on Oct. 1.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Single blind -participants are blinded Control - Placebo

Primary Sponsor: Institute - Japanese Red Cross Hokkaido College of Nursing

Condition: Condition - Healthy adult women Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to investigate the effects of four-week oral supplementation with a balenine-containing whale meat extract on skin condition in healthy female university students. Changes in skin moisture, oil content, elasticity, skin age, skin care index, skin pigmentation, and subjective skin condition before and after the intervention will be compared among the balenine, whale oil, and placebo groups to evaluate the potential beneficial effects of balenine-containing whale meat extract on skin conditioning. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Participants will orally consume soft capsules containing balenine-containing whale meat extract (100 mg of whale extract B8 plus 150 mg of safflower oil) three times daily after meals for four weeks. Interventions/Control_2 - Participants will orally consume soft capsules containing 300 mg of refined whale oil three times daily after meals for four weeks.

Eligibility: Age-lower limit - 18 years-old = Gender - Female Key inclusion criteria - 1. Healthy female university students aged 18-25 years. 2. Individuals who provide written informed consent voluntarily. 3. Individuals who agree not to substantially change their usual dietary and skin-care habits during the study period. 4. Individuals who are able to attend all scheduled measurement sessions. Key exclusion criteria - 1. Individuals with an allergy to whale meat or seafood. 2. Individuals with skin diseases such as atopic dermatitis or psoriasis. 3. Individuals currently receiving treatment for scalp disease or alopecia. 4. Pregnant or breastfeeding women. 5. Individuals judged by a physician to be unsuitable for participation in the study. Target Size - 30

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 08 Month 20 Day Date of IRB - 2026 Year 08 Month 20 Day Anticipated trial start date - 2026 Year 08 Month 20 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072211

Disclaimer: Curated by HT Syndication.